Immunoradiometric and immunohistochemical analysis of Cathepsin D in ovarian cancer: lack of association with clinical outcome
1998

Cathepsin D and Ovarian Cancer Prognosis

Sample size: 162 publication Evidence: low

Author Information

Author(s): G Ferrandina, G Scambia, A Fagotti, G D'Agostino, P Benedetti Panicci, A Carbone, S Mancuso

Primary Institution: Catholic University, Rome, Italy

Hypothesis

What is the clinical significance of Cathepsin D levels in ovarian cancer?

Conclusion

Cathepsin D measurement in tumor extracts has limited usefulness in improving the prognostic characterization of ovarian cancer patients.

Supporting Evidence

  • No correlation was found between Cathepsin D levels and clinicopathological parameters.
  • The percentage of Cathepsin D positivity was significantly higher in estrogen receptor-positive cases.
  • The 5-year overall survival rate was similar for Cathepsin D-positive and Cathepsin D-negative patients.

Takeaway

This study looked at a protein called Cathepsin D in ovarian cancer to see if it could help predict how patients would do, but it turns out it doesn't really help.

Methodology

The study analyzed Cathepsin D levels in tumor samples from 162 untreated ovarian cancer patients using immunoradiometric and immunohistochemical assays.

Limitations

The study may have included tumor samples with invading stromal and inflammatory cell contaminants, which could affect the results.

Participant Demographics

162 previously untreated patients with histologically confirmed ovarian carcinoma.

Statistical Information

P-Value

p=0.69

Statistical Significance

p=0.01

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication